Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.55 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.52 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.52 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22452057 | 1.00 | ADORA3 (0.55) | ADORA3ADORA2AADORA2BTAS1R3TAS1R1 | |
| SCHEMBL9587879 | 0.85 | ADORA3 (0.46) | ADORA3ADORA2AADORA2BADORA1 | |
| Methyl Alcohol SCHEMBL9587418 | 0.84 | ADORA3 (0.46) | ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL13312947 | 0.84 | TSHR (0.64) | ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL22452225 | 0.84 | TSHR (0.64) | ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL12157290 | 0.83 | ADORA2A (0.65) | ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL9121390 | 0.83 | ALDH1A1 (0.45) | ADORA3 | |
| SCHEMBL21427226 | 0.82 | BCHE (0.55) | ADORA2A | |
| SCHEMBL6243153 | 0.82 | BCHE (0.55) | ADORA2A | |
| SCHEMBL24021895 | 0.82 | ALDH1A1 (0.45) | ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220152077-A1 | ADENOSINE RECEPTOR AGONISTS | THE UNIVERSITY OF WARWICK (GB) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220152077-A1 | ADENOSINE RECEPTOR AGONISTS | ADORA1, ADORA2A, ADORA3 | ADORA3 3/4885ADORA2A 2/4885ADORA2B 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.